764 related articles for article (PubMed ID: 30903744)
1. N6-Methyladenosine detected in RNA of testicular germ cell tumors is controlled by METTL3, ALKBH5, YTHDC1/F1/F2, and HNRNPC as writers, erasers, and readers.
Nettersheim D; Berger D; Jostes S; Kristiansen G; Lochnit G; Schorle H
Andrology; 2019 Jul; 7(4):498-506. PubMed ID: 30903744
[TBL] [Abstract][Full Text] [Related]
2. N
von Hagen F; Gundert L; Strick A; Klümper N; Schmidt D; Kristiansen G; Tolkach Y; Toma M; Ritter M; Ellinger J
Mol Carcinog; 2021 May; 60(5):354-362. PubMed ID: 33755994
[TBL] [Abstract][Full Text] [Related]
3. METTL3 and ALKBH5 oppositely regulate m
Song H; Feng X; Zhang H; Luo Y; Huang J; Lin M; Jin J; Ding X; Wu S; Huang H; Yu T; Zhang M; Hong H; Yao S; Zhao Y; Zhang Z
Autophagy; 2019 Aug; 15(8):1419-1437. PubMed ID: 30870073
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of m6A-factors METTL3, ALKBH5, and YTHDC1 alters HPV16 mRNA splicing.
Cui X; Nilsson K; Kajitani N; Schwartz S
Virus Genes; 2022 Apr; 58(2):98-112. PubMed ID: 35190939
[TBL] [Abstract][Full Text] [Related]
5. The component of the m
Miranda-Gonçalves V; Lobo J; Guimarães-Teixeira C; Barros-Silva D; Guimarães R; Cantante M; Braga I; Maurício J; Oing C; Honecker F; Nettersheim D; Looijenga LHJ; Henrique R; Jerónimo C
J Exp Clin Cancer Res; 2021 Aug; 40(1):268. PubMed ID: 34446080
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk among writers, readers, and erasers of m
Panneerdoss S; Eedunuri VK; Yadav P; Timilsina S; Rajamanickam S; Viswanadhapalli S; Abdelfattah N; Onyeagucha BC; Cui X; Lai Z; Mohammad TA; Gupta YK; Huang TH; Huang Y; Chen Y; Rao MK
Sci Adv; 2018 Oct; 4(10):eaar8263. PubMed ID: 30306128
[TBL] [Abstract][Full Text] [Related]
7. Decreased Peripheral Blood
Luo Q; Fu B; Zhang L; Guo Y; Huang Z; Li J
Dis Markers; 2020; 2020():8193895. PubMed ID: 32685056
[TBL] [Abstract][Full Text] [Related]
8. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
[TBL] [Abstract][Full Text] [Related]
9. RNA m6A modification, signals for degradation or stabilisation?
Wei G
Biochem Soc Trans; 2024 Apr; 52(2):707-717. PubMed ID: 38629637
[TBL] [Abstract][Full Text] [Related]
10. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
11. METTL3 potentiates resistance to cisplatin through m
Wei J; Yin Y; Zhou J; Chen H; Peng J; Yang J; Tang Y
J Cell Mol Med; 2020 Oct; 24(19):11366-11380. PubMed ID: 32857912
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine RNA modification (m6A) is of prognostic value in HPV-dependent vulvar squamous cell carcinoma.
Condic M; Thiesler T; Staerk C; Klümper N; Ellinger J; Egger EK; Kübler K; Kristiansen G; Mustea A; Ralser DJ
BMC Cancer; 2022 Sep; 22(1):943. PubMed ID: 36050747
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic, progressive and prognostic performance of m
Zhuang Z; Chen L; Mao Y; Zheng Q; Li H; Huang Y; Hu Z; Jin Y
Int J Biol Sci; 2020; 16(11):1785-1797. PubMed ID: 32398949
[No Abstract] [Full Text] [Related]
15. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
16. METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation.
Zhang C; Chen L; Peng D; Jiang A; He Y; Zeng Y; Xie C; Zhou H; Luo X; Liu H; Chen L; Ren J; Wang W; Zhao Y
Mol Cell; 2020 Aug; 79(3):425-442.e7. PubMed ID: 32615088
[TBL] [Abstract][Full Text] [Related]
17. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
18. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
[TBL] [Abstract][Full Text] [Related]
19. The study of METTL14, ALKBH5, and YTHDF2 in peripheral blood mononuclear cells from systemic lupus erythematosus.
Luo Q; Rao J; Zhang L; Fu B; Guo Y; Huang Z; Li J
Mol Genet Genomic Med; 2020 Sep; 8(9):e1298. PubMed ID: 32583611
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer.
Ralser DJ; Condic M; Klümper N; Ellinger J; Staerk C; Egger EK; Kristiansen G; Mustea A; Thiesler T
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2417-2424. PubMed ID: 35731272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]